RK
Rajesh Kumar Srivastava
About Rajesh Kumar Srivastava
Data last updated:
Rajesh Kumar Srivastava is a Managing Director at Cohizon Life Sciences Limited (since 2024) and Designated Partner at Agathon Business And Consultancy Llp (since 2023). The companies operate in Chemicals and Materials, Real Estate and Construction and Service. The largest current company by reported revenue is Cohizon Life Sciences Limited at ₹1,009 Cr (FY 2025). Earlier, Rajesh Kumar Srivastava was a Director at Jubilant Bhartia Foundation (2020–2024) and Ceo at Jubilant Ingrevia Limited (2019–2023) and 8 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Managing Director | 17 Apr 2024 | 1983 | ₹1,009 Cr (FY 2025) | Active | |
| Designated Partner | 20 Nov 2023 | 2023 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 01 Apr 2020 | 2007 | ₹22.75 Cr (FY 2024) | Active | |
| Ceo | 23 Oct 2019 | 2019 | ₹4,429 Cr (FY 2026) | Active | |
| Director | 01 Apr 2017 | 2006 | ₹216 Cr (FY 2025) | Active | |
| Whole-Time Director | 17 Jan 2018 | 1978 | ₹8,346 Cr (FY 2026) | Active | |
| Director | 05 Sep 2018 | 1998 | ₹563 Cr (FY 2023) | Active | |
| Director | 28 Mar 2019 | 2019 | ₹16.2 Lakh (FY 2025) | Active | |
| Director | 02 Jun 2021 | 2021 | ₹12.56 Cr (FY 2025) | Active | |
| Director | 20 Mar 2019 | 2019 | ₹13.43 Cr (FY 2025) | Active | |
| Director | 03 Jun 2008 | 1998 | Amalgamated | ||
| Director | 05 Sep 2018 | 2004 | ₹126 Cr (FY 2019) | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Rajesh Kumar Srivastava
| Name | DIN | Company | Designation |
|---|---|---|---|
| Amit Soni | 05111144 | Cohizon Life Sciences Limited | Director |
| Anant Jain | 06648006 | Cohizon Life Sciences Limited | Director |
| Anurag Surana | 00006665 | Cohizon Life Sciences Limited | Director |
| Chandra Bose Bhardwaj | 11120939 | Cohizon Life Sciences Limited | Whole-Time Director |
| Dirk Backhaus | 06772537 | Cohizon Life Sciences Limited | Director |
| Geetesh Ahuja | Cohizon Life Sciences Limited | Cfo | |
| Neha Sureka | 10759936 | Cohizon Life Sciences Limited | Additional Director |
| Priya Virendrakumar Lohani | Cohizon Life Sciences Limited | Company Secretary | |
| Rajan Hamir Gajaria | 10145792 | Cohizon Life Sciences Limited | Director |
| Siddharth Tapaswin Patel | 07803802 | Cohizon Life Sciences Limited | Director |
| Steven Andre J Buyse | 09598298 | Cohizon Life Sciences Limited | Director |
| Jyoti Srivastava | 10379211 | Agathon Business And Consultancy Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rajesh Kumar Srivastava
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rajesh Kumar Srivastava
Rajesh Kumar Srivastava currently holds 2 directorships: Cohizon Life Sciences Limited (Managing Director, since 17 Apr 2024, revenue ₹1,009 Cr (FY 2025)); Agathon Business And Consultancy Llp (Designated Partner, since 20 Nov 2023).
Rajesh Kumar Srivastava was first appointed on 03 Jun 2008 as Director at Speciality Molecules Limited. The most recent appointment on record is 17 Apr 2024 at Cohizon Life Sciences Limited.
Rajesh Kumar Srivastava held 10 earlier board appointments: Jubilant Bhartia Foundation (Director, 01 Apr 2020 to 18 Mar 2024); Jubilant Ingrevia Limited (Ceo, 23 Oct 2019 to 30 Sep 2023); Jubilant Infrastructure Limited (Director, 01 Apr 2017 to 30 Sep 2023); Jubilant Pharmova Limited (Whole-Time Director, 17 Jan 2018 to 05 Feb 2021); Jubilant Biosys Limited (Director, 05 Sep 2018 to 27 Jan 2022); and 5 more.
The current boards of Rajesh Kumar Srivastava's companies include Amit Soni (Cohizon Life Sciences Limited), Anant Jain (Cohizon Life Sciences Limited), Anurag Surana (Cohizon Life Sciences Limited), Chandra Bose Bhardwaj (Cohizon Life Sciences Limited), Dirk Backhaus (Cohizon Life Sciences Limited), Geetesh Ahuja (Cohizon Life Sciences Limited), among others.